Mave Health Raises $2.1 Million to Expand Brain Stimulation Wearable Across India and US

Healthtech startup Mave Health has raised fresh funding to accelerate the rollout of its neuroscience-based wearable device. The company is aiming to expand into global markets while strengthening its product capabilities. 

Funding and Expansion Strategy 

The startup has raised $2.1 million in a seed funding round led by Blume Ventures, with participation from All In Capital, Inuka Capital and Stanford Angels. This takes its total funding to nearly $3 million, including a $750K pre-seed round raised in 2023. 

The capital will be used to launch its wearable headset in India and the United States, while also enhancing manufacturing capacity to support scale. The product is currently in beta, with more than 500 users onboarded following its recent release. It is available for pre-order in both markets, with shipments expected to begin next month. 

Product, Technology and User Outcomes 

Mave Health develops a non-invasive wearable headset that uses transcranial direct current stimulation technology to deliver low-intensity electrical signals to the brain. This method, based on non-invasive brain stimulation, helps regulate neural activity by either activating or calming specific regions depending on user needs. 

The device targets the prefrontal cortex, which plays a key role in attention, emotional balance and stress response. Designed for everyday use, it requires about 20 minutes per session and can operate for up to a month on a single charge. 

The company claims strong early results, with 80% of users reporting more than 60% improvement in productivity, 75% experiencing reduced stress within four weeks, and an average mood improvement of 77%. 

Market Opportunity and Industry Shift 

The company is operating in a rapidly evolving segment where wearable devices are moving beyond fitness tracking towards advanced health monitoring and mental wellness solutions. India’s healthtech market is projected to reach $21.3 billion by 2025, growing at a strong pace with over 5,200 startups driving innovation. 

There is also increasing competition in this space, with startups such as Sychedelic, Marbles Health and InnerGize gaining traction. At the same time, new entrants are exploring brain-focused technologies, reflecting a broader shift towards preventive care and technology-led health solutions. 

Read More: TIDCO to Invest ₹25 Crore Each in Agnikul and Raptee Under Startup Investment Policy 2025! 

Conclusion 

Mave Health’s funding and expansion plans highlight the growing demand for advanced wearable technologies, particularly those focused on mental performance and preventive healthcare. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.